LexDanaLexDanabeta
Inventor

Carl Kaiser

Inventor
Haddon Heights, NJ, US

Overview

50→
Patents
1976–2018
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds37%
C07CAcyclic or carbocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes14%
Y02PClimate change mitigation technologies in the production or processing of goods3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
B63BShips or other waterborne vessels1%
B63GOffensive or defensive arrangements on vessels1%
B63HMarine propulsion or steering1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,106,237Efficiency submersible thruster20185,250,537'5,6,7,8,9,10-hexahydro-7 ,10-iminocyclohept[b]indole,-6,7,8,9,10-hexahydro-7,11-imino-5H-cyclooct[ b]indole and substituted derivatives'19935,039,691'5-(1-(imidazol)methyl)-3,3-disubstituted-2(3H)furanone derivatives'19914,992,459'Dopamine-.beta.-hydroxylase inhibitors'19914,877,779'2-aminomethylalkynylalkyl-1,3-dithiane derivatives'19894,873,357'Trifluoro acetyl-cyano-aniline intermediates for dopamine-.beta.hydroxylase inhibitors'19894,863,944'Dopamine-.beta.-hydroxylase inhibitors'19894,857,540'Dopamine-.beta.-hydroxylase inhibitors'19894,810,811'Dopamine-beta-hydroxylase inhibitors'19894,772,723'Dopamine .beta.-hydroxylase inhibitors'19884,769,368'2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines'19884,767,862'Substituted tetrahydro isoquinoline intermediates'19884,761,480'P-toluene-sulfonyl-oxy substituted pyridines'19884,760,089'Irreversible dopamine-.beta.-hydroxylase inhibitors'19884,743,613'Ester prodrugs of dopamine-.beta.-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-.beta.-hydroxylase activity'19884,728,741'1-substituted-2-mercapto benzimidazole compounds and intermediates'19884,719,223'Imidazolethiol dopamine-beta-hydroxylase inhibitors'19884,707,485'Substituted te[1]trahydroisoquinoline derivatives having .beta.-adrenergic receptor activity'19874,707,488'Dopamine-.beta.-hydroxylase inhibitors and use thereof'19874,634,711'Pyridylalkyl imidazole-2-thiols'19874,628,059'Dopamine-.beta.-hydroxylase inhibitors'19864,532,331'1-Benzyl-2-aminomethyl imidazole derivatives'19854,529,604'N,N-Di-(n-Propyl)dopamine derivatives'19854,507,320'Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine'19854,382,029'Process useful for preparing 7,8-acetamido, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines'19834,327,023'Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines'19824,284,556'7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines'19814,265,890'6-Phenyl thio- and 6-cyclohexyl thio-2,3,4,5-tetrahydro-1H-3-benzazepines'19814,089,961'Antipsychotically useful quinolizidylidene derivatives of xanthenes, thioxanthenes and dibenzoxepins'19784,073,912'Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof'19784,062,961'Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase'19774,052,506'Pharmaceutical compositions and method of producing anti-Parkinsonism activity'19774,048,229'.alpha.-AMINOMETHYL-4-HYDROXY-3-METHYLSULFONYL BENZYL ALCOHOLS'19774,024,281'N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines'19774,013,777'Bis-phenoxypropanolamines'19774,012,528'.alpha.-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING .beta.-ADRENERGIC STIMULANT ACTIVITY'19774,011,319'Pharmaceutical compositions and methods involving benzazepine derivatives'19774,004,028'Phenoxypropanolamines'19773,996,383'3-Alkylamino-.alpha.-aminomethyl-4-hydroxybenzyl alcohols with .beta.-adrenergic stimulant activity'19763,988,339'Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase'19763,985,887'3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as .beta.-adrenergic stimulants'19763,976,695'Halogen substituted .alpha.-(aminoalkyl)-3,4-dihydroxybenzyl alcohols'19763,976,694'.alpha.-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylphenyl ketones'19763,966,770'4-Hydroxy-.alpha.-[(3,4-methylenedioxyphenyl)isopropylaminoethyl]-3-(meth ylsulfonylmethyl)benzyl alcohol'19763,961,076'.alpha.-Aminoalkyl-4-hydroxy-3-alkylsulfonylmethylbenzyl alcohols having .beta.-adrenergic stimulant activity'19763,952,101'.alpha.-Amino methyl-5-hydroxy-2-pyridinemethanols'19763,943,254'Beta-adrenergic antagonists'19763,943,173'3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols'19763,939,164'7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds'19763,933,913'N,N\'-bis[3-substituted-4-hydroxypheyl)-2-hydroxyethyl)] -polymethylenediamines'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1982Patents assigned to SMITHKLINE CORP (25)· patent assignee history
1976–1991Based in Haddon Heights, NJ, US· patent location history
1983–1989Patents assigned to SMITHKLINE BECKMAN CORP (19)· patent assignee history
1989Patents assigned to MARION LABORATORIES INC (1)· patent assignee history
1989–1993Based in Millersville, MD, US· patent location history
1991Patents assigned to MARION MERRELL DOW INC (1)· patent assignee history
1993Patents assigned to SCIOS NOVA INC (1)· patent assignee history
2018Based in Falmouth, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SMITHKLINE CORP251976–1982
SMITHKLINE BECKMAN CORP191983–1989
MARION LABORATORIES INC11989
MARION MERRELL DOW INC11991
SCIOS NOVA INC11993
Locations
LocationPatentsSpan
Haddon Heights, New Jersey, US461976–1991
Millersville, Maryland, US31989–1993
Falmouth, Massachusetts, US12018